Celgene: Buy on a Pullback
“So why do we like Celgene so much, and how come we have time? The main reason I like it is its...
Read MoreNov 4, 2009
“So why do we like Celgene so much, and how come we have time? The main reason I like it is its...
Read MoreNov 4, 2009
Siliconware Precision Industries Co., Ltd. (SPIL) earned a net income of NT$* 2,561 million...
Read MoreNov 4, 2009
For Immediate Release Chicago, IL – November 4, 2009 – Four free stock picks are being made...
Read MoreNov 4, 2009
IB FX View An end to the exit talk? Wednesday November 4, 2009 The two low-yielding soft...
Read MoreNov 4, 2009
Pitney Bowes Inc. (PBI) reported earnings per diluted share from continuing operations of 55...
Read MoreNov 4, 2009
Elizabeth Arden Inc.’s(RDEN) share price has entered into oversold territory with a stochastic...
Read MoreNov 4, 2009
Hawaiian Holdings Inc.’s(HA) MACD indicator has crossed over to bearish territory with a reading...
Read MoreNov 4, 2009
Maxim Integrated Products Inc.’s (MXIM) first quarter earnings beat consensus estimates by a...
Read MoreNov 4, 2009
Today’s spotlight will fall mainly on the statements coming from the Federal Reserve meeting as...
Read MoreNov 4, 2009
PS Business Parks Inc. (PSB), a real estate investment trust (REIT) that acquires, develops, owns,...
Read MoreNov 4, 2009
Onyx Pharmaceuticals (ONXX) reported third quarter earnings of 28 cents per share, well above the...
Read MoreNov 4, 2009
The ISM Non-Manufacturing Index decreased to 50.6 in October, worse than the expected increase to...
Read MoreNov 4, 2009
The EURJPY has continued up unabated in a very impressive run. Dollar sentiment still runs low but...
Read MoreNov 4, 2009
DaVita Inc. (DVA) reported third quarter net income of $110.9 million or $1.06 per share, which...
Read MoreNov 4, 2009
Yesterday, I discussed what I saw as the reasoning behind the strategy the Federal Reserve is...
Read MoreNov 4, 2009
Chinese energy giant PetroChina Co. Ltd. (PTR) announced third quarter earnings of RMB 30.8...
Read MoreNov 4, 2009
Below is a sample of our Daily Commentary. To get this comment, and our daily coverage of 15...
Read MoreNov 4, 2009
Below is a sample of our Daily Commentary. To get this comment, and our daily coverage of 15...
Read MoreNov 4, 2009
Below is a sample of our Daily Commentary. To get this comment, and our daily coverage of 15...
Read MoreNov 4, 2009
Allos Therapeutics’ (ALTH) third quarter loss per share came in at 21 cents, in line with the...
Read MoreJoin our mailing list to receive the latest news and updates from our team.

